Lilly Ventures Fund I LLC → AILERON THERAPEUTICS INC RNTX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 5.37

487,162 shares short · +9.2% vs prior

Other 13D/G Filings on AILERON THERAPEUTICS INC

Filed	Form	Filer	Stake	Shares
2021-01-08	SC	Satter Muneer A	—	—	view →
2020-06-09	SC	Satter Muneer A	—	—	view →
2020-04-16	SC	Novartis Bioventures Ltd	—	—	view →
2020-04-13	SC	Novartis Bioventures Ltd	—	—	view →
2020-03-18	SC	Novartis Bioventures Ltd	—	—	view →
2019-04-03	SC	Novartis Bioventures Ltd	—	—	view →
2019-03-18	SC	Novartis Bioventures Ltd	—	—	view →

Other Filings by Lilly Ventures Fund I LLC

Filed	Form	Issuer	Stake	Shares
2020-06-08	SC	Protagonist Therapeutics, Inc PTGX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →